Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Fourteen patients with open-angle glaucoma applied one drop 0.1% dipivalyl epinephrine topically twice daily for three years. Four of the 14 patients developed severe blepharoconjunctivitis after 17 to 26 months of exposure to this epinephrine prodrug. Two of the four patients with dipivalyl epineph...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/s0161-6420(81)35042-8
データ提供:米国国立医学図書館(NLM)
Dipivalyl Epinephrine: A Cautionary Tale in the Desert of Glaucoma Treatment
This study investigates the toxicity of dipivalyl epinephrine, a topical medication used to treat open-angle glaucoma. The researchers followed 14 patients who used dipivalyl epinephrine twice daily for three years, observing the development of severe blepharoconjunctivitis in four patients. This research highlights the importance of careful monitoring and potential risks associated with long-term use of dipivalyl epinephrine. This study serves as a reminder that even in the desert of glaucoma treatment, vigilance and careful evaluation of potential side effects are paramount.
Navigating the Shifting Sands of Glaucoma Treatment
The study underscores the importance of informed decision-making in glaucoma treatment, weighing the potential benefits of medications against the risks associated with their use. It emphasizes the need for continued monitoring and open communication between healthcare providers and patients to ensure the most effective and safe treatment approach. It's like navigating a desert landscape with a watchful eye, constantly assessing the terrain and adapting strategies to avoid potential hazards.
A Balanced Approach to Glaucoma Management
This research highlights the complexity of glaucoma management, requiring a balanced approach that considers both the benefits and potential risks of treatment options. It encourages a collaborative approach between healthcare providers and patients, ensuring informed decisions and proactive monitoring to minimize potential side effects. This journey through the desert of glaucoma treatment necessitates a careful assessment of each path and a commitment to ensuring the safest and most effective course of action.
Dr.Camel's Conclusion
This study, like a camel's cautious journey through a desert filled with potential pitfalls, reminds us of the importance of vigilant monitoring in glaucoma treatment. The potential side effects of dipivalyl epinephrine underscore the need for careful consideration of treatment options and a collaborative approach between healthcare providers and patients to ensure optimal outcomes.
Date :
- Date Completed 1981-07-20
- Date Revised 2019-07-26
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.